- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01976481
Serum 25-OH Vitamin D Modulation by Sunbed Use According to EU Guideline EN 60335-2-27
Our study aims to clarify the impact of the use of a standard sunbed according to new EU guideline EN 60335-2-27 and possibly discount the positive effects of tanning beds. We plan to investigate the serum elevation of 25(OH)D under sunbed use, respecting the new recommendations for the exposure plan for different skin types according to EN 60335-2-27.
The use of a sunbed will be compared to a control group not using a sunbed in the observation period.
- Trial with medical device
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
ZH
-
Zurich, ZH, Switzerland, 8091
- University Hospital Zurich, Division of Dermatology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria: Probands intending to use a commercial sunbed :
- Age 18 years or older
- Regular use of commercial sunbeds
- Oral and written informed consent
Exclusion criteria: 1. Skin type I according to Fitzpatrick according to EU guideline EN 60335-2-27 2. Sunbed use within the last three months 3. Use of vitamin D supplements or multivitamin supplements 4. Any medical condition which renders them unfit for sunbed use in the judgment of the investigator 5. Inability to provide oral and written consent to participate
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Sunbed
sunbed exposure
|
exposure to sunbed ultraviolet radiation
|
No Intervention: Observation
only observation of subjects recruited after randomization
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Determination of number of patients with a relevant elevation of serum 25-hydroxyvitamin D levels of =10ug/L from the baseline
Time Frame: six months
|
six months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Guenther Hofbauer, Prof MD, University Hospital Zurich, Division of Dermatology
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- sunbed study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Toxicity
-
Istituto Scientifico Romagnolo per lo Studio e...Recruiting
-
Northwestern UniversityCompleted
-
Ben-Gurion University of the NegevSoroka University Medical CenterUnknown
-
Jessa HospitalHasselt UniversityCompleted
-
Jessa HospitalHasselt UniversityRecruitingImmunotoxicity | Skin ToxicityBelgium
-
University of MiamiFlorida Breast Cancer Foundation; VAUGHN-JORDAN FOUNDATION, INC.Recruiting
-
Catalysis SLCompletedBreast Cancer | Breast Carcinoma | Adriamycin Toxicity | Cyclosporine ToxicityCuba
-
Stanford UniversityStanford Center for Asian Health Research and EducationEnrolling by invitation
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation Trust; Cambridge University Hospitals NHS Foundation...CompletedBreast Radiotherapy ToxicityUnited Kingdom
Clinical Trials on sunbed exposure
-
Istinye UniversityActive, not recruitingPulmonary PathologyTurkey
-
Radboud University Medical CenterSint MaartenskliniekCompletedPsoriasis | Psoriasis Vulgaris | Psoriatic Arthritis | Psoriatic NailNetherlands
-
Charite University, Berlin, GermanyThe Federal Office for Radiation Protection, Germany; Seibersdorf Labor GmbHCompleted
-
Emory UniversityCenters for Disease Control and PreventionWithdrawnPost Traumatic Stress Disorder, PTSD
-
University of Missouri-ColumbiaCompletedType 2 DiabetesUnited States
-
Red Maple Trials Inc.Ottawa Allergy Research CorporationCompletedAllergic Rhinitis | Rhinoconjunctivitis | ExposureCanada
-
University of WyomingUnknown
-
Uppsala UniversityRecruiting
-
University of LouisvilleCompletedAnorexia Nervosa | Bulimia Nervosa | Eating Disorder | ExposureUnited States